1 |
Iga K, Himura Y, Izumi C, Miyamoto T, Kijima K, Gen H, et al. Reversible left ventricular dysfunction associated with Guillain-Barre syndrome-an expression of catecholamine cardiotoxicity? Jpn Circ J 1995;59:236-240.
DOI
ScienceOn
|
2 |
Hiraga A, Nagumo K, Suzuki K, Sakakibara Y, Kojima S. A patient with Guillain-Barre syndrome and recurrent episodes of ST elevation and left ventricular hypokinesis in the anterior wall. No To Shinkei 2003;55:517-520.
|
3 |
Finkelstein JS, Melek BH. Guillain-Barre syndrome as a cause of reversible cardiomyopathy. Tex Heart Inst J 2006;33:57-59.
|
4 |
Bernstein R, Mayer SA, Magnano A. Neurogenic stunned myocardium in Guillain-Barre syndrome. Neurology 2000;54:759-762.
DOI
ScienceOn
|
5 |
Mayer SA, Lin J, Homma S, Solomon RA, Lennihan L, Sherman D, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 1999;30:780-786.
DOI
ScienceOn
|
6 |
Fagius J, Wallin BG. Microneurographic evidence of excessive sympathetic outflow in the Guillain-Barre syndrome. Brain 1983;106:589-600.
DOI
ScienceOn
|
7 |
Zochodne DW. Autonomic involvement in Guillain-Barre syndrome: a review. Muscle Nerve 1994;17:1145-1155.
DOI
ScienceOn
|
8 |
Pilati CF, Clark RS, Gilloteaux J, Bosso FJ, Holcomb P, Maron MB. Excessive sympathetic nervous system activity decreases myocardial contractility. Proc Soc Exp Biol Med 1990;193:225-231.
DOI
|
9 |
Ahmad J, Kham AS, Siddiqui MA. Estimation of plasma and urinary catecholamines in Guillain-Barre syndrome. Jpn J Med 1985;24:24-29.
DOI
ScienceOn
|
10 |
Martins RP, Barbarot N, Coquerel N, Baruteau AE, Kolev I, Verin M. Takotsubo cardiomyopathy associated with Guillain-Barre syndrome: a differential diagnosis from dysautonomia not to be missed. J Neurol Sci 2010;291:100-102.
DOI
ScienceOn
|